Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Adebrelimab + Apatinib in SCLC Maintenance Therapy [Phase 2]
A Phase 2 clinical trial is evaluating the combination of adebrelimab and apatinib as maintenance therapy for small cell lung cancer, curren…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer [Phase 2]
Phase 2 randomized trial comparing aldoxorubicin to topotecan in metastatic small cell lung cancer; results assess efficacy and safety.
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 3]
Phase 3 trial evaluating toripalimab alone or in combination with tifcemalimab as consolidation therapy for limited-stage small cell lung ca…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer [Phase 4]
A Phase 4 clinical trial is evaluating the therapeutic effect of irinotecan liposomes in small cell lung cancer. The study is currently recr…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) [Phase 2]
Clinical trial update on a Phase 2 study of durvalumab combined with chemoradiotherapy for limited-stage small cell lung cancer; recruitment…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating lurbinectedin with durvalumab in pre-treated patients with extensive-stage small-cell lung cancer has been withdr…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell [Phase 3]
Phase 3 trial evaluating toripalimab plus anlotinib as maintenance therapy for extensive-stage small cell lung cancer; the study status is n…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Closed vs. Open Face Masks for Cranial Radiotherapy [NA]
This clinical trial update notes the completion of a study comparing closed versus open face masks for cranial radiotherapy in patients with…
-
FDA approval · 2024-05-10FDA Approved: CISPLATIN — Original Application (Apotex Corp.)
FDA approved the original application for cisplatin from Apotex Corp., enabling the generic version to be marketed in the United States.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of carfilzomib with irinotecan in irinotecan-sensitive cancers and small cell lung cancer has com…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer [NA]
A clinical trial is evaluating whether organoid-based drug sensitivity testing from a patient's tumor can guide personalized treatment for r…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: eRAPID: Online Symptom Reporting in Lung Cancer [NA]
The eRAPID online symptom reporting study in thoracic cancers has completed, including non-small cell lung cancer, small-cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Irinotecan hydrochloride liposome injection (LY01610) for Small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer [Phase 1, Phase 2]
A two-part Phase 1/2 trial of BIW-8962 as monotherapy in lung cancer has been terminated; the study evaluated Non-Small Cell Lung Cancer, Sm…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma [Phase 1]
Phase 1 clinical trial of SNC115 injections for patients with recurrent/refractory small cell lung cancer and large cell neuroendocrine carc…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is ongoing to evaluate LY01610 in patients with relapsed small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases [Phase 2]
A Phase 2 trial investigating chemotherapy plus atezolizumab for extensive-stage small cell lung cancer with untreated asymptomatic brain me…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: BMS-986012 in Relapsed/Refractory SCLC [Phase 1, Phase 2]
Phase 1/2 trial updates for BMS-986012 in relapsed/refractory small cell lung cancer are completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of FR901228 in patients with refractory or progressive small cell lung cancer or non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Phase IIII Study of AL8326 in Small Cell Lung Cancer [Phase 3]
A Phase III trial update for AL8326 in small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Prospective Clinicogenomic Program [Phase 4]
A Phase 4 prospective clinicogenomic program in progress for non-small cell lung cancer and small-cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial update examining the efficacy and biomarker explanation of IBI-322 combined with lenvatinib in extensive-stage small cell lung…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers [Phase 1, Phase 2]
NCI-sponsored Phase 1/2 trial evaluating PLX038 (PEGylated SN38) in combination with Rucaparib in solid tumors and small cell cancers, with …
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects [Phase 2]
Phase 2 trial evaluating the combination of durvalumab (MEDI4736) and AZD6738 in relapsed small cell lung cancer has completed.